Advent Venture Partners leads Avidex funding

Advent Venture Partners, the technology venture capitalist, has invested £4m (€6.3m), as part of a £10m funding round, in Avidex, the spin-out from Oxford University's Institute of Molecular Medicine.

Avidex was founded in 1999 on funding of £1.7m from private investors and the Oxford Technology Venture Capital Trust.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump